Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01836029
Title Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors VentiRx Pharmaceuticals Inc.
Indications

head and neck squamous cell carcinoma

Therapies

Cisplatin

Cetuximab + Fluorouracil

Carboplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.